| Symbol | CVM |
|---|---|
| Name | CEL SCI CORP |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Biological Products, (No Diagnostic Substances) |
| Address | 8229 BOONE BLVD ., VIENNA, VA 22182 |
| Telephone | 7035069460 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000725363 |
| Description | None |
CEL-SCI Study Published in Peer-Reviewed Oral Oncology Supports Multikines Biomarker Strategy and Potential Overall Survival Benefit Ahead of Head and Neck Cancer Confirmatory Registration Study
Read moreNew Form DEF 14A - CEL SCI CORP <b>Filed:</b> 2026-07-02 <b>AccNo:</b> 0001654954-26-006496 <b>Size:</b> 907 KB
Read moreTALOR EYAL 🟢 acquired 2.3K shares of CEL SCI CORP (CVM) at $1.04 Transaction Date: Jun 30, 2026 | Filing ID: 000003
Read morePRICHEP PATRICIA B 🟢 acquired 4.1K shares of CEL SCI CORP (CVM) at $1.04 Transaction Date: Jun 30, 2026 | Filing ID: 000003
Read moreDirector KERSTEN GEERT R 🟢 acquired 5.2K shares of CEL SCI CORP (CVM) at $1.04 Transaction Date: Jun 30, 2026 | Filing ID: 000006
Read moreCEL-SCI and Saudi Amarox Hold Strategic Agreement Signing Ceremony at BIO 2026, Advancing U.S.–Saudi Cooperation in Cancer Care
Read moreCEL-SCI Advances Multikine® Immunotherapy for Head and Neck Cancer Through Dual U.S. Registration Study and Saudi Market Entry Strategy
Read moreNew Form 424B5 - CEL SCI CORP <b>Filed:</b> 2026-06-15 <b>AccNo:</b> 0001654954-26-005987 <b>Size:</b> 1 MB
Read more